ETON - CIK 0001710340
Eton Pharmaceuticals, Inc. has filed 371 documents with the SEC between 2017 and 2026. The most frequent type is major company event (142 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| New insider ownership | 3 | 2024-09-12 | 2024-09-09 |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| Major company event (amended) | 8-K/A | 2024-08-02 | 2024-06-11 |
| Major company event | 8-K | 2024-07-15 | 2024-07-15 |
| Major company event | 8-K | 2024-06-21 | 2024-06-14 |
| Major company event | 8-K | 2024-06-11 | 2024-06-11 |
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Activist ownership stake (update) | SC 13D/A | 2024-04-30 | - |
| Major company event | 8-K | 2024-04-30 | 2024-04-30 |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-11 |
| Major company event | 8-K | 2024-04-18 | 2024-04-15 |
| Employee stock plan | S-8 | 2024-03-26 | - |
| Annual report (amended) | 10-K/A | 2024-03-22 | 2023-12-31 |
| Major company event | 8-K | 2024-03-22 | 2024-03-22 |
| Annual report | 10-K | 2024-03-14 | 2023-12-31 |
| Major company event | 8-K | 2024-03-14 | 2024-03-14 |
| Major company event | 8-K | 2024-02-21 | 2024-02-21 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Major company event | 8-K | 2024-02-02 | 2024-02-02 |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Major company event | 8-K | 2023-10-04 | 2023-10-04 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-07-05 | 2023-06-30 |
| Major company event | 8-K | 2023-06-28 | 2023-06-28 |
| Major company event | 8-K | 2023-06-15 | 2023-06-09 |
| Major company event | 8-K | 2023-06-13 | 2023-06-13 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-10 | 2023-05-10 |
| EFFECT | - | 2023-05-02 | - |
| Company correspondence | CORRESP | 2023-05-01 | - |
| Proxy statement | DEF 14A | 2023-04-27 | 2023-04-27 |
| SEC correspondence | UPLOAD | 2023-04-12 | - |
| Securities registration | S-3 | 2023-04-07 | - |
| Employee stock plan | S-8 | 2023-03-21 | - |
| Annual report | 10-K | 2023-03-16 | 2022-12-31 |
| Major company event | 8-K | 2023-03-16 | 2023-03-16 |
| Major company event | 8-K | 2023-03-15 | 2023-03-15 |
| Major company event | 8-K | 2023-03-13 | 2023-03-13 |